To reward young investigators who have focused on clinical or basic research in haemophilia and von Willebrand disease and to encourage their continued studies in the field.


The Martin Villar Award offers EUR 50,000 to two applicants whose proposal best exemplifies the program's objectives, as assessed by an independent Review Committee.  Funding is intended to support a 12 month project. One award is for clinical research and one is for basic research.


Applications are evaluated based on four criteria:

  • Scientific merit
  • Innovation
  • Clinical / medical impact
  • Quality of research environment


Scientists or clinicians up to 40 years of age with an innovative idea relevant to haemophilia and von Willebrand disease pathologies or management with plasma-derived protein therapies are invited to apply for the Martin Villar Award.  Applications are encouraged from either individuals or research teams who are engaged in research at Universities, hospitals, or independent research institutions.


Eligible applicants must submit a CV and a Letter of Intent outlining the aims of their research project.  Application letters that fulfill the terms of entry will be assessed and judged by a Review Committee comprised of five experts from healthcare, research, and industry.  Based on their review, the Committee will invite several candidates to submit a full research proposal.  The Review Committee will evaluate the research proposals and select the award recipient.